1. Home
  2. SIBN

as 11-15-2024 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Founded: 2008 Country:
United States
United States
Employees: N/A City: SANTA CLARA
Market Cap: 557.9M IPO Year: 2018
Target Price: $23.43 AVG Volume (30 days): 504.2K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.91 EPS Growth: N/A
52 Week Low/High: $11.76 - $21.70 Next Earning Date: 11-12-2024
Revenue: $157,035,000 Revenue Growth: 18.98%
Revenue Growth (this year): 21.87% Revenue Growth (next year): 17.34%

SIBN Daily Stock ML Predictions

Stock Insider Trading Activity of SI-BONE Inc. (SIBN)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
DUNN JEFFREY W SIBN Director Nov 4 '24 Sell $13.55 341 $4,620.55 22,040
RECUPERO ANTHONY J SIBN President, Commercial Ops Oct 2 '24 Sell $13.59 4,226 $57,402.83 235,163
Maheshwari Anshul SIBN Chief Financial Officer Oct 2 '24 Sell $13.58 3,305 $44,886.32 198,813
Maheshwari Anshul SIBN Chief Financial Officer Sep 3 '24 Sell $16.35 1,414 $23,118.90 198,813

Share on Social Networks: